Autologous adipose tissue injection versus platelet-rich plasma (PRP) injection in the treatment of knee osteoarthritis: a randomized, controlled study – study protocol

Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage h...

Full description

Saved in:
Bibliographic Details
Published inBMC musculoskeletal disorders Vol. 21; no. 1; pp. 314 - 8
Main Authors Bąkowski, Paweł, Kaszyński, Jakub, Wałecka, Joanna, Ciemniewska-Gorzela, Kinga, Bąkowska-Żywicka, Kamilla, Piontek, Tomasz
Format Journal Article
LanguageEnglish
Published London BioMed Central 20.05.2020
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-2474
1471-2474
DOI10.1186/s12891-020-03345-8

Cover

Abstract Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov , trial registration number: NCT04321629 , retrospectively registered on date of registration.
AbstractList Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods.BACKGROUNDKnee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods.This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction.METHODSThis is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction.This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.DISCUSSIONThis study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration.TRIAL REGISTRATIONname of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration.
Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration. Keywords: Autologous subcutaneous adipose tissue, Platelet rich plasma, Knee OA, Intra- articular injection
Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov , trial registration number: NCT04321629 , retrospectively registered on date of registration.
Abstract Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov , trial registration number: NCT04321629 , retrospectively registered on date of registration.
Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration.
Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.
Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration.
ArticleNumber 314
Audience Academic
Author Kaszyński, Jakub
Piontek, Tomasz
Bąkowski, Paweł
Wałecka, Joanna
Ciemniewska-Gorzela, Kinga
Bąkowska-Żywicka, Kamilla
Author_xml – sequence: 1
  givenname: Paweł
  orcidid: 0000-0001-8661-7754
  surname: Bąkowski
  fullname: Bąkowski, Paweł
  email: pawel.bakowski@rehasport.pl
  organization: Department of Orthopedic Surgery, Rehasport Clinic
– sequence: 2
  givenname: Jakub
  surname: Kaszyński
  fullname: Kaszyński, Jakub
  organization: Department of Orthopedic Surgery, Rehasport Clinic
– sequence: 3
  givenname: Joanna
  surname: Wałecka
  fullname: Wałecka, Joanna
  organization: Department of Orthopedic Surgery, Rehasport Clinic
– sequence: 4
  givenname: Kinga
  surname: Ciemniewska-Gorzela
  fullname: Ciemniewska-Gorzela, Kinga
  organization: Department of Orthopedic Surgery, Rehasport Clinic
– sequence: 5
  givenname: Kamilla
  surname: Bąkowska-Żywicka
  fullname: Bąkowska-Żywicka, Kamilla
  organization: Institute of Bioorganic Chemistry Polish Academy of Sciences
– sequence: 6
  givenname: Tomasz
  surname: Piontek
  fullname: Piontek, Tomasz
  organization: Department of Orthopedic Surgery, Rehasport Clinic, Department of Spine Disorders and Pediatric Orthopedics, University of Medical Sciences Poznan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32434498$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_wAiyQJTZFIsW3iR0WSKOKS6VKVAjWluOczHhI7MF2KpUV78Bb8Fg8CZ7OMMxUqMoijv39_8k5_o-LA-cdFMVTgs8IkdWrSKisSYkpLjFjfFLKB8UR4YKUlAt-sLM-LI5jXGBMhGT1o-KQUc44r-VR8Ws6Jt_7mR8j0q1d-ggo2RhHQNYtwCTrHbqGEPP5stcJekhlsGa--oqDRqdXn65e7LDWoTTPHgF0GsAl5Dv01QEgHxN4HdI82FzgNdIoaNf6wX6H9iUy3qXg-x5aFNPY3qDfP35uVsvgkze-f1w87HQf4cnmfVJ8eff28_mH8vLj-4vz6WVpKsFSqU3NG1KL1kjRsFZ33EhJeIe5npCqqQ1IYQTpRAeEUEKBUsMoqSddQ0TLMDspLta-rdcLtQx20OFGeW3V7YYPM5XbsKYHNdEYhJFV14DhtJLSMFY1QoLklGBaZa83a6_l2AzQmjyQoPs90_0TZ-dq5q-VoBzXdZ0NTjcGwX8bISY12Gig77WDfGcqY5N891LwjD6_gy78GFweVaYIryRjGd1SM50bsK7zua5ZmappRQWvKlKTTJ39h8pPC4PNdwWdzft7gme7jW47_Ju0DNA1YIKPMUC3RQhWqzirdZxVjrO6jbNaieQdkbFJr3KWf8f290vZWhpzHTeD8G8a96j-AEdtDEo
CitedBy_id crossref_primary_10_1016_j_msksp_2024_102983
crossref_primary_10_1186_s13018_021_02851_2
crossref_primary_10_3390_biomedicines10102527
crossref_primary_10_1016_j_bonr_2022_101601
crossref_primary_10_1186_s13018_020_01991_1
crossref_primary_10_3390_biomedicines10030684
crossref_primary_10_1177_23259671231155950
crossref_primary_10_1292_jvms_20_0730
crossref_primary_10_1007_s00402_021_03979_w
Cites_doi 10.1177/0363546512471299
10.1007/s11926-017-0652-x
10.1002/sctm.18-0122
10.5114/aoms.2015.52126
10.1016/j.joca.2006.05.008
10.1016/j.arth.2018.12.001
10.1111/1756-185X.13139
10.3727/096368912X657855
10.1016/j.semarthrit.2013.07.003
10.1136/bmjopen-2014-006947
10.5966/sctm.2015-0245
10.1093/asj/sjv135
10.2174/1573397113666170829155149
10.1016/j.arthro.2015.08.005
10.1016/j.arthro.2016.09.024
10.1007/s00264-018-4182-6
10.1016/j.joca.2013.07.017
10.1016/j.jvir.2017.08.004
10.1007/BF03325265
10.1111/1756-185X.13233
10.1007/s11136-011-9903-x
10.1002/14651858.CD005523.pub3
10.1177/0363546517716641
10.2519/jospt.2008.2657
10.1053/joca.2002.0807
10.1016/j.stem.2011.06.008
10.1016/j.imlet.2015.06.005
10.5966/sctm.2016-0023
10.1016/j.joca.2015.08.009
10.1016/j.stem.2008.08.008
10.1093/rheumatology/38.9.870
10.1089/ten.TEA.2012.0225
10.1016/j.gaitpost.2016.12.005
10.1186/1477-7525-1-64
10.1186/1477-7525-11-107
10.1016/j.arthro.2015.09.010
10.1186/s13075-018-1621-0
10.1186/1471-2474-14-337
10.1186/s12891-018-2105-8
10.1016/j.arthro.2018.01.048
10.1186/1477-7525-1-17
10.1002/jgm.3002
10.1093/rheumatology/kem234
10.1016/j.semarthrit.2017.03.007
10.1177/0363546516665809
10.1177/0363546505280214
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RV
7TK
7TS
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12891-020-03345-8
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
ProQuest Nursing & Allied Health Database
Neurosciences Abstracts
Physical Education Index
ProQuest Health & Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
ProQuest Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Physical Education Index
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals - Free
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Physical Therapy
EISSN 1471-2474
EndPage 8
ExternalDocumentID oai_doaj_org_article_5a0e7c86fbec42688c336b78e8421026
PMC7240999
A627466191
32434498
10_1186_s12891_020_03345_8
Genre Clinical Trial Protocol
Journal Article
GeographicLocations Poland
GeographicLocations_xml – name: Poland
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7TK
7TS
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c673t-ac94b197dc87b3daf4c8814f04a516b9ce87c71f7fe11212e22c32195fb17d303
IEDL.DBID 7X7
ISSN 1471-2474
IngestDate Wed Aug 27 01:05:08 EDT 2025
Thu Aug 21 18:06:05 EDT 2025
Thu Sep 04 17:50:55 EDT 2025
Fri Jul 25 04:05:16 EDT 2025
Tue Jun 17 21:29:51 EDT 2025
Tue Jun 10 20:49:53 EDT 2025
Mon Jul 21 06:06:40 EDT 2025
Thu Apr 24 22:51:54 EDT 2025
Tue Jul 01 01:09:01 EDT 2025
Sat Sep 06 07:22:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Platelet rich plasma
Knee OA
Autologous subcutaneous adipose tissue
Intra- articular injection
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c673t-ac94b197dc87b3daf4c8814f04a516b9ce87c71f7fe11212e22c32195fb17d303
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
ORCID 0000-0001-8661-7754
OpenAccessLink https://www.proquest.com/docview/2414683353?pq-origsite=%requestingapplication%
PMID 32434498
PQID 2414683353
PQPubID 44767
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_5a0e7c86fbec42688c336b78e8421026
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7240999
proquest_miscellaneous_2405334874
proquest_journals_2414683353
gale_infotracmisc_A627466191
gale_infotracacademiconefile_A627466191
pubmed_primary_32434498
crossref_primary_10_1186_s12891_020_03345_8
crossref_citationtrail_10_1186_s12891_020_03345_8
springer_journals_10_1186_s12891_020_03345_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-20
PublicationDateYYYYMMDD 2020-05-20
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-20
  day: 20
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC musculoskeletal disorders
PublicationTitleAbbrev BMC Musculoskelet Disord
PublicationTitleAlternate BMC Musculoskelet Disord
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References PB Fodor (3345_CR48) 2016; 36
N Bellamy (3345_CR22) 1997; 24
EM Roos (3345_CR45) 2003; 1
PD Nguyen (3345_CR41) 2017; 6
W Hermann (3345_CR2) 2018; 14
CH Jo (3345_CR50) 2017; 45
Y Zhu (3345_CR30) 2013; 21
J Pintat (3345_CR46) 2017; 28
AI Caplan (3345_CR37) 2011; 9
RC Pereira (3345_CR33) 2013; 19
Ewa M Roos (3345_CR28) 2003; 1
J Pak (3345_CR47) 2013; 14
KL Bennell (3345_CR31) 2017; 19
WL Dai (3345_CR10) 2017; 33
AI Caplan (3345_CR38) 2008; 3
3345_CR29
D Garay-Mendoza (3345_CR13) 2018; 21
Dominik Golicki (3345_CR23) 2017; 1
Duško Spasovski (3345_CR49) 2018; 20
A Fearon (3345_CR27) 2017; 52
JE Brazier (3345_CR52) 1999; 38
AD Woolf (3345_CR4) 2003; 81
AF Anderson (3345_CR19) 2006; 34
J Chahla (3345_CR1) 2018; 34
PT Paradowski (3345_CR18) 2013; 11
S Patel (3345_CR12) 2013; 41
D Xing (3345_CR11) 2017; 20
R Theiler (3345_CR21) 2002; 10
PT Paradowski (3345_CR17) 2015; 5
C Bartholdy (3345_CR6) 2017; 47
TS Yeung (3345_CR25) 2008; 38
T Piontek (3345_CR20) 2012; 77
YG Koh (3345_CR40) 2016; 32
YS Kim (3345_CR43) 2016; 24
EM Roos (3345_CR16) 2003; 1
RE Delanois (3345_CR8) 2019; 34
M Herdman (3345_CR24) 2011; 20
EM Bartels (3345_CR7) 2016; 3
A Schiavone Panni (3345_CR15) 2019; 43
3345_CR3
A Goldberg (3345_CR26) 2012; 24
M Hiligsmann (3345_CR5) 2013; 43
WS Lee (3345_CR51) 2019; 8
YM Pers (3345_CR42) 2016; 5
F Bianchi (3345_CR14) 2013; 22
E Anitua (3345_CR35) 2007; 46
AI Caplan (3345_CR39) 2015; 168
CJ Meheux (3345_CR9) 2016; 32
Y Di (3345_CR36) 2018; 20
BJ Cole (3345_CR34) 2017; 45
K Akeda (3345_CR32) 2006; 14
G Cattaneo (3345_CR44) 2018; 19
References_xml – volume: 41
  start-page: 356
  issue: 2
  year: 2013
  ident: 3345_CR12
  publication-title: Am J Sports Med
  doi: 10.1177/0363546512471299
– volume: 19
  start-page: 24
  issue: 5
  year: 2017
  ident: 3345_CR31
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-017-0652-x
– volume: 8
  start-page: 504
  issue: 6
  year: 2019
  ident: 3345_CR51
  publication-title: Stem Cells Transl Med
  doi: 10.1002/sctm.18-0122
– volume: 1
  start-page: 191
  year: 2017
  ident: 3345_CR23
  publication-title: Archives of Medical Science
  doi: 10.5114/aoms.2015.52126
– volume: 14
  start-page: 1272
  issue: 12
  year: 2006
  ident: 3345_CR32
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2006.05.008
– volume: 34
  start-page: 801
  issue: 4
  year: 2019
  ident: 3345_CR8
  publication-title: J Arthroplast
  doi: 10.1016/j.arth.2018.12.001
– volume: 21
  start-page: 140
  issue: 1
  year: 2018
  ident: 3345_CR13
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.13139
– volume: 22
  start-page: 2063
  issue: 11
  year: 2013
  ident: 3345_CR14
  publication-title: Cell Transplant
  doi: 10.3727/096368912X657855
– volume: 43
  start-page: 303
  issue: 3
  year: 2013
  ident: 3345_CR5
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2013.07.003
– volume: 5
  start-page: e006947
  issue: 7
  year: 2015
  ident: 3345_CR17
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2014-006947
– volume: 5
  start-page: 847
  issue: 7
  year: 2016
  ident: 3345_CR42
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2015-0245
– volume: 36
  start-page: 229
  issue: 2
  year: 2016
  ident: 3345_CR48
  publication-title: Aesthet Surg J
  doi: 10.1093/asj/sjv135
– volume: 14
  start-page: 108
  issue: 2
  year: 2018
  ident: 3345_CR2
  publication-title: Curr Rheumatol Rev
  doi: 10.2174/1573397113666170829155149
– volume: 32
  start-page: 495
  issue: 3
  year: 2016
  ident: 3345_CR9
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2015.08.005
– volume: 33
  start-page: 659
  issue: 3
  year: 2017
  ident: 3345_CR10
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2016.09.024
– volume: 43
  start-page: 7
  issue: 1
  year: 2019
  ident: 3345_CR15
  publication-title: Int Orthop
  doi: 10.1007/s00264-018-4182-6
– volume: 21
  start-page: 1627
  issue: 11
  year: 2013
  ident: 3345_CR30
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2013.07.017
– volume: 28
  start-page: 1708
  issue: 12
  year: 2017
  ident: 3345_CR46
  publication-title: J Vasc Interv Radiol
  doi: 10.1016/j.jvir.2017.08.004
– volume: 81
  start-page: 646
  issue: 9
  year: 2003
  ident: 3345_CR4
  publication-title: Bull World Health Organ
– volume: 24
  start-page: 339
  issue: 4
  year: 2012
  ident: 3345_CR26
  publication-title: Aging Clin Exp Res
  doi: 10.1007/BF03325265
– volume: 20
  start-page: 1612
  issue: 11
  year: 2017
  ident: 3345_CR11
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.13233
– volume: 77
  start-page: 115
  year: 2012
  ident: 3345_CR20
  publication-title: Pol Orthop Traumatol
– volume: 20
  start-page: 1727
  issue: 10
  year: 2011
  ident: 3345_CR24
  publication-title: Qual Life Res
  doi: 10.1007/s11136-011-9903-x
– volume: 3
  start-page: CD005523
  year: 2016
  ident: 3345_CR7
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD005523.pub3
– volume: 45
  start-page: 2774
  issue: 12
  year: 2017
  ident: 3345_CR50
  publication-title: Am J Sports Med
  doi: 10.1177/0363546517716641
– volume: 38
  start-page: 410
  issue: 7
  year: 2008
  ident: 3345_CR25
  publication-title: J Orthop Sports Phys Ther
  doi: 10.2519/jospt.2008.2657
– volume: 10
  start-page: 479
  issue: 6
  year: 2002
  ident: 3345_CR21
  publication-title: Osteoarthr Cartil
  doi: 10.1053/joca.2002.0807
– volume: 9
  start-page: 11
  issue: 1
  year: 2011
  ident: 3345_CR37
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2011.06.008
– volume: 168
  start-page: 136
  issue: 2
  year: 2015
  ident: 3345_CR39
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2015.06.005
– volume: 6
  start-page: 187
  issue: 1
  year: 2017
  ident: 3345_CR41
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2016-0023
– volume: 24
  start-page: 237
  issue: 2
  year: 2016
  ident: 3345_CR43
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2015.08.009
– volume: 3
  start-page: 229
  issue: 3
  year: 2008
  ident: 3345_CR38
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2008.08.008
– volume: 38
  start-page: 870
  issue: 9
  year: 1999
  ident: 3345_CR52
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/38.9.870
– volume: 19
  start-page: 1476
  issue: 11–12
  year: 2013
  ident: 3345_CR33
  publication-title: Tissue Eng Part A
  doi: 10.1089/ten.TEA.2012.0225
– ident: 3345_CR3
– ident: 3345_CR29
– volume: 52
  start-page: 237
  year: 2017
  ident: 3345_CR27
  publication-title: Gait Posture
  doi: 10.1016/j.gaitpost.2016.12.005
– volume: 1
  start-page: 64
  issue: 1
  year: 2003
  ident: 3345_CR28
  publication-title: Health and Quality of Life Outcomes
  doi: 10.1186/1477-7525-1-64
– volume: 24
  start-page: 2413
  issue: 12
  year: 1997
  ident: 3345_CR22
  publication-title: J Rheumatol
– volume: 1
  start-page: 64
  year: 2003
  ident: 3345_CR16
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-1-64
– volume: 11
  start-page: 107
  year: 2013
  ident: 3345_CR18
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-11-107
– volume: 32
  start-page: 97
  issue: 1
  year: 2016
  ident: 3345_CR40
  publication-title: Arthroscopy.
  doi: 10.1016/j.arthro.2015.09.010
– volume: 20
  start-page: 128
  issue: 1
  year: 2018
  ident: 3345_CR36
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-018-1621-0
– volume: 14
  start-page: 337
  year: 2013
  ident: 3345_CR47
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-14-337
– volume: 19
  start-page: 176
  issue: 1
  year: 2018
  ident: 3345_CR44
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/s12891-018-2105-8
– volume: 34
  start-page: 1719
  issue: 5
  year: 2018
  ident: 3345_CR1
  publication-title: Arthroscopy.
  doi: 10.1016/j.arthro.2018.01.048
– volume: 1
  start-page: 17
  year: 2003
  ident: 3345_CR45
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-1-17
– volume: 20
  start-page: e3002
  issue: 1
  year: 2018
  ident: 3345_CR49
  publication-title: The Journal of Gene Medicine
  doi: 10.1002/jgm.3002
– volume: 46
  start-page: 1769
  issue: 12
  year: 2007
  ident: 3345_CR35
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kem234
– volume: 47
  start-page: 9
  issue: 1
  year: 2017
  ident: 3345_CR6
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2017.03.007
– volume: 45
  start-page: 339
  issue: 2
  year: 2017
  ident: 3345_CR34
  publication-title: Am J Sports Med
  doi: 10.1177/0363546516665809
– volume: 34
  start-page: 128
  issue: 1
  year: 2006
  ident: 3345_CR19
  publication-title: Am J Sports Med
  doi: 10.1177/0363546505280214
SSID ssj0017839
Score 2.3225408
Snippet Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability...
Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social...
Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability...
Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability...
Abstract Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 314
SubjectTerms Adipose tissue
Adipose Tissue - transplantation
Arthritis
Autografts
Autologous subcutaneous adipose tissue
Body fat
Bone surgery
Care and treatment
Cartilage
Cartilage (articular)
Cartilage diseases
Clinical Trials, Phase II as Topic
Contraction
Disease
Epidemiology
Exercise
Humans
Injection
Injections, Intra-Articular
Internal Medicine
Intra- articular injection
Isometric
Joint surgery
Knee
Knee OA
Manipulative therapy
Medical research
Medicine
Medicine & Public Health
Mesenchyme
Orthopedics
Orthopedics and biomechanics
Osteoarthritis
Osteoarthritis, Knee - therapy
Pain
Pain Measurement
Patient Reported Outcome Measures
Patients
Physical therapy
Platelet rich plasma
Platelet-Rich Plasma - metabolism
Platelets
Prospective Studies
Quality of Life
Questionnaires
Randomized Controlled Trials as Topic
Rehabilitation
Rheumatology
Social interactions
Sports Medicine
Stem cell transplantation
Stem cells
Study Protocol
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LjtMwFLXQrNggYHgEBmQkxENMNHHtxA67ghiNkEAjxEizs_xUA61T0c5iZsU_8Bd8Fl_CtZOUZhCwYdfUN6kfx_fR3HuM0GNdGYi5vI0bqc6ZdzRXunR5WWtutHC8TkVi795XRyfs7Wl5unXUV8wJ6-iBu4k7KFXhuBGVhx8DayKEobTSXDjBYrSSyLaLuhiCqf79AQe7P5TIiOpgBVo4ZvhAqFRQyspcjMxQYuv_XSdvGaXLCZOX3pomY3R4HV3rvUg87Xp_A11x4SbanQaIoBfn-AlOeZ3pD_Nd9H16ls6ohRAfK9ss25XD6zTduAmfUiZWwDE5A9qXc3A9YSVz0I6zeLVaKPzs-MPx8y3ZJmDwGvEmRR23Hn8OzuFYL9LCjM4SUdJLrDAYQtsumgtn93GfFD93FidOW_zj67f-UySLaAGRt9DJ4ZuPr4_y_oSG3FScrnNlaqZJza0RXFOrPDNCEOYLpkpS6do4wQ0nnnsHfh2ZuMnEUNCRpdeEW7Cet9FOaIO7izAjlnhjwd3QhjFTaKogmCIGMEQjaDJEhgWTpqcvj6dozGUKY0Qlu0WWsMgyLbIUGXqxuWfZkXf8VfpVxMFGMhJvpy8AjrKHo_wXHDP0NKJIRvUA3TOqr3KAQUaiLTmNZx2BT1STDO2NJGFbm3HzgEPZq5WVBHeLVbFMjmbo0aY53hlT5YIDJIFMV17NWYbudLDdDAm8Z8pYDUPlI0CPxjxuCc0skY5zeC4EExnaH6D_q1t_ntN7_2NO76Ork7R1S9Dpe2hn_eXMPQBXcK0fpl3_E1GeXI0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD4a44UXLhuXwEBGQlzEMuraiR0khApimpBAFVqlvVmx49BCm5ReJMYT_4F_wc_il3DsXLaMsbemtqM45zu3-FwAHunYoM-VZ46RkpDnloWpjmwYJVoYLa1IfJLYh4_xwYi_P4qONqBpd1S_wOW5rp3rJzVaTPe-fzt-jQz_yjO8jF8sUca6-B10hHqM8SiUl-CyPy9yoXz85FRBoDXQJM6cu66jnHwN_38l9SlVdTaM8sxZqldR-9fham1bkkEFhhuwYYst2B4U6FfPjslj4qM9_Wf0Lbg2rAlEDqu6Atvwe7D2zWzL9ZKk2WReLi1ZebqQSfHFh2wVxEVx4Ph8ijYqkjxEMTp2V8tZSp4OPw2fnZo7KQial6SNZSdlTr4W1hKXWFIiZse-otJLkhLUmFk5m_yw2S6po-enNiO--C358_NX_ctVlSgRujdhtP_u8O1BWLdyCE0s2CpMTcI1TURmpNAsS3NupKQ87_E0orFOjJXCCJqL3KIBSPu23zcMhWmUayoyVLO3YLMoC3sHCKcZzU2Gdok2nJueZil6XdQg2JhDVwC0oaEydZ1z125jqry_I2NV0V0h3ZWnu5IBPG_XzKsqHxfOfuOg0c50Fbr9H-Xis6oZXkVpzwoj4xyZBK0gKQ1jsRbSSu687DiAJw5YyiEbH8-kdToEbtJV5FID1xQJjaeEBrDTmYn8b7rDDTRVwz4K0c9jl0_HAnjYDruVLqausIgknFPlYQsewO0Kye2W0MxmnCe4VdHBeGfP3ZFiMvbVyQXeF72OAHYbbjh5rP-_07sX7-IeXOl7Po1QrO_A5mqxtvfRGlzpB57F_wLBdF4k
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZgSIgXBBuXjIGMhLiIRatrx3Z4KxXThDQ0ISbtzYodWy20TrV2D_DEf-Bf8LP4JRw7bmjGReKtqY-jOOc7t_icY4SeaG4g5nJ1EKQyZ87SvNKFzYtSC6OlFWUsEjt-x49O2duz4iy1yQm1MJv790TygyXoz5CbA0HOgFJW5PIqulaA4g1oHvNxt2MgwNKvi2L-OK9neGJ__t-18IYZupwieWmfNJqfw1voZvIb8ahl9G10xfpttDPyEDPPP-OnOGZyxk_k2-j6cdow30HfRxfxgFqI73FVTxfN0uJVfNd46j_GNCyPQ2YGjC9m4HcCG3NQjZNwtZxX-PnJ-5MXG7RTj8FlxF1-Om4c_uStxaFYpAEcTmKXpFe4wmAF62Y-_WLrfZwy4me2xrGhLf7x9Vv6FTpFNADHO-j08M2H8VGejmfIDRd0lVemZJqUojZSaFpXjhkpCXMDVhWE69JYKYwgTjgLTh0Z2uHQUFCQhdNE1GA676It33h7H2FGauJMDb6GNoyZgaYVRFLEAIBoQEyGyJp3yqTe5eEIjZmKMYzkquW3An6ryG8lM_Sym7NoO3f8k_p1gERHGbpuxz8AjCoJsSqqgRVGcgfAB89GSkMp10JayULkzDP0LABKBd0Aj2eqVOIAiwxdttQoHHQEDlFJMrTXowSZNv3hNSRV0ilLBb4W46FGjmbocTccZoY8OW8BSUDT1lYLlqF7LYK7JYHrTBkrYamih-3emvsjfjqJHccF3BciiQztr6Xg12P9_Z3u_h_5A3RjGOW1ANW9h7ZW5xf2IXh8K_0oivpPCtBQtQ
  priority: 102
  providerName: Springer Nature
Title Autologous adipose tissue injection versus platelet-rich plasma (PRP) injection in the treatment of knee osteoarthritis: a randomized, controlled study – study protocol
URI https://link.springer.com/article/10.1186/s12891-020-03345-8
https://www.ncbi.nlm.nih.gov/pubmed/32434498
https://www.proquest.com/docview/2414683353
https://www.proquest.com/docview/2405334874
https://pubmed.ncbi.nlm.nih.gov/PMC7240999
https://doaj.org/article/5a0e7c86fbec42688c336b78e8421026
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3bbtMw1ILthRcuG7DAqIyEuIhFq2sndnhBWbVpqrSpGqvUNyt2HFpok7J2D_DEP_AXfBZfwrHjZssQe0nb-KTN6bk754LQKxVriLmK3ApSErLC0DBTkQmjRHGthOGJKxI7OY2PR2wwjsZ-w23p0yrXOtEp6rzSdo98HywNi22FEP24-BbaqVH26aofoXEXbcJPUTu6gY-bgItwsP7rQhkR7y9BF9s8HwiYupSyKBQtY-R69v-rma-ZpptpkzeenTqTdPQQ3fe-JE5r4j9Cd0y5hbbTEuLo-Xf8GrvsTrdtvoUeDD1B8HndR2Ab_U4v3fBaiP1xlk8X1dLglaMDnpZfXIpWiW3WBqwvZuCTAolDUJsT-2k5z_Db4dnw3TXYaYnBncRN7jquCvy1NAbbQpIKeHTiOih9wBkGC5lX8-kPk-9hny0_Mzl2zW7xn5-__DvbRaICVn2MRkeH5_3j0I9uCHXM6SrMdMIUSXiuBVc0zwqmhSCs6LIsIrFKtBFcc1LwwoDDR3qm19MUlGdUKMJzMKtP0EZZlWYHYUZyUugc_BClGdNdRTOIsogG5qKWmwJE1jSU2vc1t-M1ZtLFNyKWNd0l0F06uksRoPfNNYu6q8et0AeWNRpI25HbnaguPksv4DLKuoZrERcgFOD1CKEpjRUXRjAbVccBemMZS1q9AbenM1_-AEjaDlwytUOQwFlKSIB2W5Ag77q9vGZN6fXNUl5JR4BeNsv2SptDVxrgJICp6645C9DTmpMblMCtpowlgCpv8XgL5_ZKOZ24buQcvheijADtraXh6rb-_58-ux2L5-hez8lpBGp8F22sLi7NC_D-VqrjRLyDNtN08GkArweHp8MzONuP-x23owLHEybgOOqlfwFAPGGv
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtMwGLZGdwE3HDYOgQFG4igWramd2EGaUAebOnZQNXXS7kziOLTQJmVphcYV78Bb8BA8DE_Cb8fJliF2t7s0dqK4__ef7P-A0NM4kOBzpYlmpNClqSJuFPvK9cOYyZgrFpoksb39oHdIPxz5Rwvod5ULo8MqK5loBHWSS71HvgaahgY6Q4i8nX51ddcofbpatdCIbGuFZN2UGLOJHTvq5Bu4cMX69nug97NOZ2tz8K7n2i4DrgwYmbmRDGnshSyRnMUkiVIqOfdo2qaR7wVxKBVnknkpSxXYJl5HdTqSAJ_7aeyxBDQAvPcKWqR6A6WFFjc29_sH9TkGA_ujStXhwVoB2kBHGoHL1iaE-i5vqEPTNeBf3XBGOZ4P3Dx3emuU4tZNdN1as7hbwu8WWlDZElruZuDJT07wc2ziS83G_RK60beQwIOyksEy-tWdm_a5-bzAUTKa5oXCM4MEPMo-myCxDOu4ERifjsEqBpC5ILiH-lcxifDL_kH_1Zm5owyDQYvr6Hmcp_hLphTWqSw5cMnQ1HB6gyMMOjrJJ6PvKlnFNl5_rBJsyu3iPz9-2itdxyIHZrmNDi-FrHdQK8szdQ9h6iVeKhOwhGJJqWzHJAI_z5MAb6Lx7CCvoqGQtrK6bvAxFsbD4oEo6S6A7sLQXXAHva6fmZZ1RS6cvaGhUc_UNcHNjfz4k7AiRvhRWzHJgxTYEuwuziUhQcy44lT79YGDXmhgCS254PNkZBMwYJG6Bpjo6jZMYK6FnoNWGjNB4sjmcAVNYSVeIU7500FP6mH9pI7iyxQgCeaUmd-MOuhuieR6SWDYE0pDWCprYLyx5uZINhqaeugM3gt-joNWK244_az__6f3L17FY3S1N9jbFbvb-zsP0LWO4VkflMoKas2O5-oh2KKz-JFleIw-XraM-Qtij540
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZbxMxELagSBUvCFqOhQJGQhyiq8axd-3lLRxROVpFiEp9s9YXCSTeqEkf4In_wL_gZ_FLGHs3S7YcEm-b9TiyM9c38cwYofsq1xBzORMUqUiZszQtVWbTrFBcK2F5EYvEDg7z_SP2-jg7Xqvij9nuqyPJuqYhdGnyy725cbWKi3xvAVY1ZOxA6NOjlGWpOI8uMPDVIanrqD9ozxE4-P9Vqcwf53XcUeza_7ttXnNOZxMnz5yeRqc0vIwuNWgSD2r2X0HnrN9C2wMPkfTsM36AY35n_ON8C20eNMfo2-j74DReWwtRPy7NZF4tLF5GDuCJ_xiTszwO-RowPp8CGgXmpmAwx-HTYlbiR6N3o8drtBOPAUjiNmsdVw5_8tbiUEJSgXSOY--kp7jE4BtNNZt8sWYXN3nyU2twbHOLf3z91jyF_hEVCOlVdDR8-f75ftpc2pDqnNNlWuqCKVJwowVX1JSOaSEIcz1WZiRXhbaCa04cdxagHunbfl9TMJuZU4QbcKjX0IavvL2BMCOGOG0AgSjNmO4pWkJ8RTSIFQ1ylCCy4p3UTUfzcLHGVMbIRuSy5rcEfsvIbykS9KSdM6_7efyT-lkQiZYy9OKOL6qTD7JRbZmVPcu1yB2oA-AdITSlueLCChbi6TxBD4NAyWAxYHm6bAofYJOh95YchOuPACYVJEE7HUrQdN0dXomkbCzNQgICY3monKMJutcOh5khe85bkCSgqSuuOUvQ9VqC2y0BoKaMFbBV3pHtzp67I34yjn3IOXwvxBcJ2l1pwa9l_f03vfl_5HfR5ujFUL59dfjmFrrYj6qbgW3fQRvLk1N7GyDhUt2JWv8Tk8VcCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autologous+adipose+tissue+injection+versus+platelet-rich+plasma+%28PRP%29+injection+in+the+treatment+of+knee+osteoarthritis%3A+a+randomized%2C+controlled+study+%E2%80%93+study+protocol&rft.jtitle=BMC+musculoskeletal+disorders&rft.au=B%C4%85kowski%2C+Pawe%C5%82&rft.au=Kaszy%C5%84ski%2C+Jakub&rft.au=Wa%C5%82ecka%2C+Joanna&rft.au=Ciemniewska-Gorzela%2C+Kinga&rft.date=2020-05-20&rft.pub=BioMed+Central&rft.eissn=1471-2474&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12891-020-03345-8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2474&client=summon